Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia

@article{Schomacher2008EndocannabinoidsMN,
  title={Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia},
  author={M. Schomacher and H. M{\"u}ller and C. Sommer and S. Schwab and W. Sch{\"a}bitz},
  journal={Brain Research},
  year={2008},
  volume={1240},
  pages={213-220}
}
The endocannabinoids anandamide (AEA) and palmitoylethanolamide (PEA) act as endogenous protective factors of the brain, using different pathways of neuroprotection against neuronal damage. Although several in vivo and in vitro studies confirmed the neuroprotective efficacy of endocannabinoids, no experimental settings compare and explore the neuroprotective potential of AEA and PEA in an acute stroke model. In this study, we investigated the neuroprotective potential by infarct measurement… Expand
58 Citations
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
  • 44
  • PDF
Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion
  • 9
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion
  • 9
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo
  • 195
  • PDF
...
1
2
3
4
5
...